ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Nath Bio-Genes (India) Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b). This disclosure provides the updated distribution of shareholding across various investor categories.
Nath Bio-Genes (India) Limited submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The auditor reported nil non-compliance, confirming the company's strong governance standards.
Nath Bio-Genes (India) Ltd confirmed it is not a Large Corporate under SEBI norms. The company reported zero outstanding long-term borrowings as of March 2026.